ESR1 and breast carcinoma: The gut microbiome composition of breast cancer patients differs based on their estrogen receptor (ER) status, with patients with ER‐positive breast cancer having a higher abundance of Lactobacillus and Bifidobacterium, while patients with ER‐negative breast cancer had a higher abundance of Fusobacterium.66